Kineta, Inc. Changes Certifying Accountant
| Field | Detail |
|---|---|
| Company | Kineta, Inc./De |
| Form Type | 8-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, corporate-action
TL;DR
Kineta switched auditors, filing an 8-K on 3/28/25 for the change effective 3/27/25.
AI Summary
Kineta, Inc. (formerly Yumanity Therapeutics, Inc. and Proteostasis Therapeutics, Inc.) filed an 8-K on March 28, 2025, reporting a change in its certifying accountant as of March 27, 2025. The company, incorporated in Delaware with its principal executive offices in Mercer Island, WA, is in the Pharmaceutical Preparations industry.
Why It Matters
A change in a company's auditor can sometimes signal underlying issues or a desire for a fresh perspective on financial reporting.
Risk Assessment
Risk Level: low — This filing solely reports a change in the company's auditor, which is a routine administrative event.
Key Players & Entities
- KINETA, INC. (company) — Registrant
- YUMANITY THERAPEUTICS, INC. (company) — Former Company Name
- PROTEOSTASIS THERAPEUTICS, INC. (company) — Former Company Name
- March 27, 2025 (date) — Date of earliest event reported
- March 28, 2025 (date) — Filing Date
FAQ
What is the primary reason for Kineta, Inc. filing this 8-K?
Kineta, Inc. is filing this 8-K to report a change in its certifying accountant, effective March 27, 2025.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on March 28, 2025.
What were Kineta, Inc.'s previous names?
Kineta, Inc. was formerly known as Yumanity Therapeutics, Inc. and Proteostasis Therapeutics, Inc.
In which state is Kineta, Inc. incorporated?
Kineta, Inc. is incorporated in Delaware.
What is Kineta, Inc.'s primary business sector?
Kineta, Inc. operates in the Pharmaceutical Preparations sector, with SIC code 2834.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 28, 2025 regarding KINETA, INC./DE.